1. Home
  2. EVGOW vs RZLT Comparison

EVGOW vs RZLT Comparison

Compare EVGOW & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EVgo Inc.

EVGOW

EVgo Inc.

N/A

Current Price

$0.03

Market Cap

0.0

ML Signal

N/A

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$2.48

Market Cap

326.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVGOW
RZLT
Founded
2010
2010
Country
United States
United States
Employees
331
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
326.4M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
EVGOW
RZLT
Price
$0.03
$2.48
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$9.17
AVG Volume (30 Days)
22.5K
2.1M
Earning Date
03-07-2025
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.32
EPS
N/A
N/A
Revenue
$239,306,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
73.08
N/A
52 Week Low
$0.01
$1.07
52 Week High
$0.38
$11.46

Technical Indicators

Market Signals
Indicator
EVGOW
RZLT
Relative Strength Index (RSI) 30.30 35.46
Support Level $0.01 $1.87
Resistance Level $0.08 $2.82
Average True Range (ATR) 0.01 0.24
MACD -0.00 -0.08
Stochastic Oscillator 25.61 15.93

Price Performance

Historical Comparison
EVGOW
RZLT

About EVGOW EVgo Inc.

EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: